MYLK and infectious disease: In addition to the pathways that appeared in the enrichment analysis, GSK3B was mapped to the “Immune System” pathways “B cell receptor signaling pathway” and “Chemokine signaling pathway,” and MYLK was mapped to “Platelet receptor signaling pathway.” Regarding infectious diseases, GSK3B was mapped to “Amoebiasis,” “Epstein–Barr virus infection,” “HTLV-I infection,” “Influenza A,” and “Measles.”